Premium Information is available for this item - Upgrade for $1 a day
6505-01-293-9357
Usp Medroxyprogesterone Acetate Tablets
6505012939357 012939357 NDC00047-0874-29 PROVERA
January 2023
7
Marketplace 6505-01-293-9357
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-293-9357 5+ Documents (More...)
Medroxyprogesterone Acetate Tablets 271-7665 6505-00-890-1355 6505-01-326-5248 6505-27-000-6581 6505-01-293-9357
6505-01-184-1249 6505-33-189-9395 271-7665 6505-00-890-1355 6505-01-326-5248 6505-27-000-6581 6505-01-293-9357
-127-4046 Usp Medroxyprogesterone Acetate Tablets 890-1355 6505-01-326-5248 6505-27-000-6581 6505-01-293-9357
-246-1917 Usp Medroxyprogesterone Acetate Tablets, Acetate Tablets 326-5248 6505-27-000-6581 6505-01-293-9357
Usp Medroxyprogesterone Acetate Tablets 127-4046 6505-01-289-9825 6505-01-271-7665 Related to 6505-01-293-9357
127-4046 6505-01-289-9825 6505-01-271-7665 6505-00-890-1355 6505-01-326-5248 6505-27-000-6581 6505-01-293-9357
web browser . 6505-99-009-4710Medroxyprogesterone Acetate Tablets6505990094710 990094710 2316198 PROVERA
Usp Medroxyprogesterone Acetate Tablets PROVERA https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505
Usp Medroxyprogesterone Acetate Tablets PROVERA TABLETS NDC00009-0064-06 Managed by United States
DOSEPAK TABLETS PROVERA TABLETS NDC00009-0050-08 Managed by United States NSN 01RNCC DOSEPAK PROVERA
Restrictions 6505-01-293-9357
6505-01-293-9357 is a Usp Medroxyprogesterone Acetate Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-293-9357
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-293-9357
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-293-9357
- Part Number
- Manufacturer
- Status
- NDC00047-0874-29
- Manufacturer
- 04534 - Warner-Chilcott Laboratories Div Of (Obsolete)
- Original Design
- Original Design
- PROVERA
- 04534 - Warner-Chilcott Laboratories Div Of (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-293-9357
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 10.000 Milligrams Medroxyprogesterone Acetate Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 250.000 Tablets
- Total Primary Container Quantity [CSCW]
- 12
Management Data 6505-01-293-9357
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Feb 1989
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 250 Tt
- 00000000250TT
- K
NATO Stock Numbers Related to 6505-01-293-9357
Freight Information 6505-01-293-9357
6505-01-293-9357 has freight characteristics.. 6505-01-293-9357 has a variance between NMFC and UFC when transported by rail and the description should be consulted.